Ameriprise’s Achillion Pharmaceuticals ACHN Stock Holding History

Ameriprise’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,640	Closed	-$64K	–	3799
2019 Q4	$64K	Buy	+10,640	New	+$61.6K	﹤0.01%	3661
2019 Q2	–	Sell	-59,210	Closed	-$175K	–	3829
2019 Q1	$175K	Hold	59,210	–	–	﹤0.01%	3572
2018 Q4	$94K	Hold	59,210	–	–	﹤0.01%	3537
2018 Q3	$218K	Hold	59,210	–	–	﹤0.01%	3527
2018 Q2	$168K	Sell	59,210 -200	-0.3%	-$681	﹤0.01%	3517
2018 Q1	$221K	Buy	59,410 +210	+0.4%	+$687	﹤0.01%	3452
2017 Q4	$170K	Buy	+59,200	New	+$215K	﹤0.01%	3501
2015 Q2	–	Sell	-160,635	Closed	-$1.58M	–	4102
2015 Q1	$1.58M	Sell	160,635 -81,780	-34%	-$1.02M	﹤0.01%	2698
2014 Q4	$2.97M	Buy	242,415 +135,687	+127%	+$1.66M	﹤0.01%	2364
2014 Q3	$1.06M	Buy	106,728 +106,578	+71,052%	+$989K	﹤0.01%	2773
2014 Q2	$1K	Buy	+150	New	+$599	﹤0.01%	5418
2013 Q4	–	Sell	-175,009	Closed	-$528K	–	5531
2013 Q3	$528K	Buy	175,009 +17,140	+11%	+$117K	﹤0.01%	2876
2013 Q2	$1.29M	Buy	+157,869	New	+$1.21M	﹤0.01%	2527

Ameriprise's ACHN Position: Q1 2020 in Review

Ameriprise sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 10,640 shares — an estimated $64K sold.

Ameriprise first reported a position in ACHN in Q2 2013 and held it in 13 quarters. The position peaked at $2.97M in Q4 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Ameriprise reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Ameriprise sold 10,640 Achillion Pharmaceuticals shares in Q1 2020, an estimated $64K.
Ameriprise first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 13 quarters.
Ameriprise's Achillion Pharmaceuticals position peaked at $2.97M in Q4 2014.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Ameriprise's 13F filing for Q1 2020, filed 15 May 2020.